- Home
- MTEX vs ATHA Comparison
MTEX vs ATHA Comparison
Compare MTEX & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEX
- ATHA
- Stock Information
- Founded
- MTEX 1993
- ATHA 2011
- Country
- MTEX United States
- ATHA United States
- Employees
- MTEX N/A
- ATHA N/A
- Industry
- MTEX Medicinal Chemicals and Botanical Products
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- MTEX Health Care
- ATHA Health Care
- Exchange
- MTEX Nasdaq
- ATHA Nasdaq
- Market Cap
- MTEX 21.2M
- ATHA 21.0M
- IPO Year
- MTEX 1999
- ATHA 2020
- Fundamental
- Price
- MTEX $7.93
- ATHA $0.26
- Analyst Decision
- MTEX
- ATHA Buy
- Analyst Count
- MTEX 0
- ATHA 4
- Target Price
- MTEX N/A
- ATHA $11.25
- AVG Volume (30 Days)
- MTEX 4.6K
- ATHA 205.0K
- Earning Date
- MTEX 05-13-2025
- ATHA 05-14-2025
- Dividend Yield
- MTEX N/A
- ATHA N/A
- EPS Growth
- MTEX N/A
- ATHA N/A
- EPS
- MTEX 1.32
- ATHA N/A
- Revenue
- MTEX $117,866,000.00
- ATHA N/A
- Revenue This Year
- MTEX N/A
- ATHA N/A
- Revenue Next Year
- MTEX N/A
- ATHA N/A
- P/E Ratio
- MTEX $6.38
- ATHA N/A
- Revenue Growth
- MTEX N/A
- ATHA N/A
- 52 Week Low
- MTEX $6.75
- ATHA $0.25
- 52 Week High
- MTEX $16.49
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- MTEX 25.06
- ATHA 28.14
- Support Level
- MTEX $8.21
- ATHA $0.25
- Resistance Level
- MTEX $9.20
- ATHA $0.31
- Average True Range (ATR)
- MTEX 0.51
- ATHA 0.03
- MACD
- MTEX -0.13
- ATHA -0.00
- Stochastic Oscillator
- MTEX 7.42
- ATHA 8.41
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.